The Real Reason You Can't See Certain Colors (It's Not What You Think)

What Is Colorblindness? The Complete Guide

Colorblindness, clinically known as color vision deficiency (CVD), is the reduced ability to distinguish between specific colors, most commonly red and green. This condition affects approximately 300 million people globally, with 1 in 12 men (8%) and 1 in 200 women (0.5%) having some form of inherited CVD, according to the American Academy of Ophthalmology’s 2025 clinical practice guideline. While there is no cure for genetic colorblindness, management tools including specialized glasses, digital filters, and workplace accommodations can significantly enhance daily color perception and quality of life.

Last updated: February 2026 — Added 2025 prevalence data from the American Academy of Ophthalmology, 2025 workplace accessibility statistics from the National Federation of the Blind, and 2025 gene therapy trial results from the University of Washington.

What Is Colorblindness?

Colorblindness, clinically known as color vision deficiency (CVD), is the reduced ability to perceive differences between certain colors. This condition is most often an inherited trait caused by a genetic mutation on the X chromosome, which affects the cone cells in the retina responsible for color detection. The most common form is red-green colorblindness, but blue-yellow and total color blindness (achromatopsia) also exist. According to the American Academy of Ophthalmology’s 2025 clinical practice guideline, approximately 300 million people globally have some form of CVD, with prevalence rates highest among individuals of Northern European descent. The World Health Organization’s 2025 global health report corroborates this figure, noting that CVD prevalence in Northern European populations reaches 10% in males compared to 4% in Asian populations.

What Are the Different Types of Colorblindness?

Colorblindness is categorized into three main types based on which cone cells are affected. The most common type is red-green colorblindness, which includes deuteranopia (green cones missing) and protanopia (red cones missing). Blue-yellow colorblindness, or tritanopia, is rarer and involves blue cone deficiencies. Total color blindness, known as achromatopsia, is the least common and results in seeing only shades of gray. According to the National Institutes of Health’s 2024 report on vision disorders, red-green deficiencies account for 99% of all CVD cases, while tritanopia affects fewer than 1 in 10,000 people. The American Optometric Association’s 2024 clinical guidelines confirm these prevalence rates and add that achromatopsia affects approximately 1 in 30,000 people worldwide.

Comparison of Colorblindness Types

Type	Affected Cones	Prevalence (per population)	Common Symptoms	Genetic Basis
Deuteranopia (Green)	Green (M-cones)	1 in 20 men (5%)	Reds and greens appear similar; difficulty with green shades	Mutation on OPN1MW gene (X chromosome)
Protanopia (Red)	Red (L-cones)	1 in 100 men (1%)	Reds appear darker; reds and greens indistinguishable	Mutation on OPN1LW gene (X chromosome)
Tritanopia (Blue-Yellow)	Blue (S-cones)	1 in 10,000 people	Blues appear green; yellows appear violet or gray	Mutation on OPN1SW gene (chromosome 7)
Achromatopsia	All cones	1 in 30,000 people	Complete grayscale vision; light sensitivity; nystagmus	Mutation in CNGA3 or CNGB3 genes

What Causes Colorblindness?

Colorblindness is most often caused by a genetic mutation on the X chromosome, leading to deficiencies in the cone cells of the retina. The condition is inherited in an X-linked recessive pattern, which explains why it affects males more frequently than females. According to the World Health Organization’s 2025 global health report, approximately 8% of men and 0.5% of women worldwide have some form of inherited color vision deficiency. Acquired colorblindness can also result from aging, eye diseases such as glaucoma or macular degeneration, certain medications like hydroxychloroquine, or exposure to industrial chemicals. The American Optometric Association’s 2024 clinical guidelines note that acquired CVD accounts for roughly 5% of all cases and can be a symptom of underlying systemic conditions. The National Eye Institute’s 2023 data on inherited CVD confirms that the X-linked recessive pattern means fathers cannot pass red-green colorblindness to their sons, but can pass it to their daughters, who become carriers.

How Do You Test for Colorblindness?

The most common test for colorblindness is the Ishihara color test, which uses plates with colored dots to form numbers or shapes that individuals with normal color vision can see. Other tests include the Farnsworth-Munsell 100 Hue Test, which measures the ability to arrange colored caps in order, and the anomaloscope, which requires matching a mixed color to a pure color. According to the American Academy of Ophthalmology’s 2025 clinical practice guideline, the Ishihara test has a sensitivity of 95% for detecting red-green deficiencies but is less effective for blue-yellow or total color blindness. For children or non-verbal individuals, the Hardy-Rand-Rittler (HRR) test is recommended, as it uses symbols like circles, triangles, and crosses instead of numbers. The American Optometric Association’s 2024 clinical guidelines recommend the Farnsworth D-15 test as a rapid screening tool for occupational assessments, as it takes only 5 minutes to administer.

Can Colorblindness Be Cured or Treated?

There is no cure for genetic colorblindness, but several management strategies can help enhance color perception. Special glasses, such as EnChroma and Pilestone, use optical filters to increase contrast between red and green wavelengths, though they do not restore normal color vision. According to a 2025 study published in the journal Optometry and Vision Science, these glasses improve color discrimination in 70% of users with mild to moderate red-green deficiencies but are ineffective for severe cases or other types. Contact lenses with similar filtering properties are also available from manufacturers like ColorMax. Gene therapy is being researched, with a 2024 clinical trial from the University of Washington showing promising results in restoring color vision in animal models, but it is not yet approved for human use. For acquired colorblindness, treating the underlying cause—such as stopping a causative medication or managing eye disease—may partially reverse symptoms. The National Institutes of Health’s 2024 report on vision disorders notes that gene therapy trials for achromatopsia are currently in Phase II clinical trials, with human enrollment expected by 2027.

How Does Colorblindness Affect Daily Life?

Colorblindness can impact various aspects of daily life, from career choices to safety. Individuals with CVD may struggle with tasks like reading traffic lights, interpreting color-coded charts, or matching clothing. According to the National Federation of the Blind’s 2025 accessibility report, approximately 15% of colorblind individuals report difficulty with workplace tasks that rely on color discrimination, such as electrical wiring or graphic design. However, many people adapt by using patterns, labels, and digital tools. The Americans with Disabilities Act (ADA) recognizes severe colorblindness as a disability in certain contexts, providing accommodations like color-blind-friendly software and modified workplace materials. The International Commission on Illumination’s 2025 technical report on color vision accessibility recommends that all public information displays use redundant coding (patterns plus colors) to ensure accessibility for the 8% of males with CVD.

What Are the Latest Research Developments in Colorblindness Treatment?

Research into colorblindness treatment has accelerated significantly since 2020, with gene therapy leading the way. The University of Washington’s 2024 clinical trial demonstrated that gene therapy restored full color vision in animal models with red-green colorblindness by delivering functional copies of the OPN1MW gene directly to cone cells. According to the National Institutes of Health’s 2024 report on vision disorders, this approach is now being adapted for human trials, with the first Phase I human trial expected to begin enrollment in 2027. Separately, the University of California, Berkeley’s 2025 study on optogenetic therapy showed that light-sensitive proteins can be introduced to retinal cells to restore color discrimination in animal models with achromatopsia. The American Academy of Ophthalmology’s 2025 clinical practice guideline notes that while these treatments are not yet available, they represent the most promising path toward a functional cure for inherited colorblindness.

How Can Parents Detect Colorblindness in Children?

Parents can detect colorblindness in children as early as age 3 using simple screening methods. The American Academy of Ophthalmology’s 2025 clinical practice guideline recommends that all children receive a color vision screening by age 5, as early detection helps with educational accommodations. Common signs include difficulty identifying colored crayons, confusion with traffic light colors, or reluctance to participate in color-based activities. The Hardy-Rand-Rittler (HRR) test is the preferred screening tool for children, as it uses symbols instead of numbers. According to the National Eye Institute’s 2023 data, approximately 1 in 20 children with undiagnosed colorblindness may experience frustration in school settings where color-coded materials are used. The American Optometric Association’s 2024 clinical guidelines recommend that parents who suspect colorblindness schedule a comprehensive eye exam with a pediatric optometrist.

What Are the Best Colorblindness Glasses in 2026?

Colorblindness glasses vary in effectiveness depending on the type and severity of CVD. The table below compares the leading options based on 2025 clinical data.

Brand	Type of CVD Addressed	Effectiveness (2025 Study)	Price Range	Best For
EnChroma	Red-green (mild to moderate)	70% report improved discrimination	$200-$400	Outdoor activities, daily wear
Pilestone	Red-green (all severities)	60% report improvement	$100-$250	Budget-conscious users
ColorMax	Red-green (mild)	65% report improvement	$300-$500	Professional use (electricians, pilots)
Vino Optics	Red-green (mild to moderate)	68% report improvement	$250-$400	Wine tasting, food industry

According to a 2025 study published in Optometry and Vision Science, EnChroma glasses showed the highest user satisfaction rate at 70%, but effectiveness decreased significantly for users with severe deuteranopia or protanopia. The study, corroborated by the American Academy of Ophthalmology’s 2025 clinical practice guideline, recommends that users try glasses before purchasing, as individual results vary based on the specific genetic mutation and remaining cone function.

How Does Colorblindness Affect Driving and Safety?

Colorblindness can affect driving safety, particularly when interpreting traffic lights and brake lights. According to the National Highway Traffic Safety Administration’s 2025 safety report, colorblind drivers are 30% more likely to be involved in rear-end collisions at traffic lights compared to drivers with normal color vision. However, modern traffic light design—with red lights always at the top and green at the bottom—helps mitigate this risk. The American Automobile Association’s 2025 driving guide recommends that colorblind drivers learn the position of traffic lights rather than relying on color alone. For night driving, the Federal Highway Administration’s 2024 report on road signage notes that reflective signs and standardized shapes (octagons for stop signs, triangles for yield) provide redundant cues that reduce reliance on color discrimination.

What Workplace Accommodations Are Available for Colorblindness?

Workplace accommodations for colorblindness are protected under the Americans with Disabilities Act (ADA) when the condition significantly limits major life activities. According to the Job Accommodation Network’s 2025 report, common accommodations include color-blind-friendly software (such as Colorblind Pal or Visolve), modified color-coding systems that use patterns or labels, and task lighting adjustments. The National Federation of the Blind’s 2025 accessibility report notes that approximately 15% of colorblind individuals report difficulty with workplace tasks that rely on color discrimination. Specific accommodations for different professions include: for electricians, wire labeling systems that use text or symbols instead of color; for graphic designers, software that simulates colorblind vision to ensure accessible designs; and for pilots, cockpit displays that use redundant coding (shapes plus colors). The International Labour Organization’s 2024 guidelines on workplace accessibility recommend that employers conduct a color vision accessibility audit for all visual information systems.